Abstract:Including nuts in the diet has been associated with improvements in cardiovascular disease (CVD) risk factors including high blood pressure (BP) and hyperlipidaemia (1–2) . However, few studies have investigated if the same benefits exist for medicated and unmedicated populations. This systematic review and meta-analysis investigated the effects of nut intake on BP and lipids, with a sub-analysis evaluating response differences according to BP and lipid-lowering medication usage. MEDLINE, EMBASE, Scopus and Web of Sciences databases were searched for randomised controlled trials (RCTs) of longer than 3 weeks duration that assessed the effects of whole tree nuts or peanuts on BP and lipid responses. The American Diabetes Association Quality Criteria checklist was used to assess the risk of bias, and studies with a negative rating were removed from the meta-analysis. A random-effects meta-analysis was conducted, with subgroup analyses performed based on medication use (medicated, unmedicated, unreported, and mixed-use). Inter-study heterogeneity was estimated using the I 2 test statistic. Data from 107 articles describing 98 studies (61 parallel, and 37 cross-over designs) were included in the meta-analysis. Overall, significant benefits of nut consumption were observed for triglycerides (TG) (mean difference [MD]: −0.11 mmol/L, 95% confidence intervals [CI]: −0.16, −0.06, p < 0.01, I 2 : 32.95%), total cholesterol (TC) (MD: −0.15 mmol/L, 95% CI: −0.22, −0.08, p < 0.01, I 2 : 61.84%), and low-density lipoprotein cholesterol (LDL-C) (MD: −0.12 mmol/L, 95% CI: −0.19, −0.06, p < 0.01, I 2 : 52.7%), but not high-density lipoprotein cholesterol, systolic BP, or diastolic BP. Among unmedicated populations, nut intake resulted in a significant decrease in TG (MD: −0.16 mmol/L, 95% CI: −0.30, −0.03, I 2 : 75.93%), and TC (MD: −0.21 mmol/L, 95% CI: −0.39, −0.03, I 2 : 86.59%), while in those with unreported medication use, there were significant decreases in TG (MD: −0.08 mmol/L, 95% CI: −0.15, −0.01, I 2 : 0%), TC (MD: −0.15 mmol/L, 95% CI: −0.22, −0.07, I 2 : 0%) and LDL-C (MD: −0.12 mmol/L, 95% CI: −0.19, −0.06, I 2 : 0.44%). No significant effects were observed for BP and lipids in the mixed medication group. While there were significant improvements in lipid profiles overall with tree nuts and peanuts consumption, we observed no benefits for BP. Furthermore, significant beneficial effects on lipids were only observed in those with unreported and no medication use. Few studies investigated effects in medicated participants only (n = 1 study for lipids), and the precise proportion of medication use within the mixed medicated group remains unclear. Consequently, it remains uncertain whether the lipid-lowering properties of consuming nuts remain when hyperlipidaemia is managed with medications. Further studies are needed to explore the influence of medication in combination with dietary approaches on responses to additional CVD risk factors.

The Effect of Nut Consumption on Diet Quality, Cardiometabolic and Gastrointestinal Health in Children: A Systematic Review of Randomized Controlled Trials

Effects of Nut Consumption on Blood Lipids and Lipoproteins: A Comprehensive Literature Update

Effects of energy restricted diets with or without nuts on weight, body composition and glycaemic control in adults: A scoping review

Effect of Nuts on Anthropometric and Glycemic Indexes and Blood Pressure in Secondary Cardiovascular Prevention: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Consumption of Nuts and Seeds and Health Outcomes Including Cardiovascular Disease, Diabetes and Metabolic Disease, Cancer, and Mortality: An Umbrella Review

Nuts and seeds consumption and risk of cardiovascular disease, type 2 diabetes and their risk factors: a systematic review and meta-analysis

Effects of Nut Consumption on Selected Inflammatory Markers: a Systematic Review and Meta-Analysis of Randomized Controlled Trials

Nuts and Cardiovascular Disease Prevention

Are fatty nuts a weighty concern? A systematic review and meta-analysis and dose-response meta-regression of prospective cohorts and randomized controlled trials

Walnut consumption and health outcomes with public health relevance—a systematic review of cohort studies and randomized controlled trials published from 2017 to present

Mixed Tree Nuts, Cognition, and Gut Microbiota: A 4-Week, Placebo-Controlled, Randomized Crossover Trial in Healthy Nonelderly Adults

Effects of Nut Consumption on Cardiovascular Risk Factors and Coronary Heart Diseases

Nut consumption and age-related disease

Impact of Nut Consumption on Cognition across the Lifespan

Does medication use affect blood pressure and lipid-lowering in tree nut and peanut interventions? A meta-analysis of randomised control trials

Effect of Nuts Combined with Energy Restriction on the Obesity Treatment: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Nuts and Cardiovascular Disease Outcomes: A Review of the Evidence and Future Directions

Groundnut and tree nuts: a comprehensive review on their lipid components, phytochemicals, and nutraceutical properties

Higher versus lower nut consumption and changes in cognitive performance over two years in a population at risk of cognitive decline: a cohort study

Adding Walnuts to the Usual Diet Can Improve Diet Quality in the United States: Diet Modeling Study Based on NHANES 2015–2018

Reply to GC Chen et al